| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |